Correlation Between LLOYDS and Silo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both LLOYDS and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LLOYDS and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LLOYDS BKG GROUP and Silo Pharma, you can compare the effects of market volatilities on LLOYDS and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LLOYDS with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of LLOYDS and Silo Pharma.

Diversification Opportunities for LLOYDS and Silo Pharma

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between LLOYDS and Silo is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding LLOYDS BKG GROUP and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and LLOYDS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LLOYDS BKG GROUP are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of LLOYDS i.e., LLOYDS and Silo Pharma go up and down completely randomly.

Pair Corralation between LLOYDS and Silo Pharma

Assuming the 90 days trading horizon LLOYDS BKG GROUP is expected to generate 6.21 times more return on investment than Silo Pharma. However, LLOYDS is 6.21 times more volatile than Silo Pharma. It trades about 0.04 of its potential returns per unit of risk. Silo Pharma is currently generating about 0.0 per unit of risk. If you would invest  9,814  in LLOYDS BKG GROUP on September 3, 2024 and sell it today you would earn a total of  71.00  from holding LLOYDS BKG GROUP or generate 0.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy80.4%
ValuesDaily Returns

LLOYDS BKG GROUP  vs.  Silo Pharma

 Performance 
       Timeline  
LLOYDS BKG GROUP 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LLOYDS BKG GROUP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, LLOYDS is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Silo Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Silo Pharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

LLOYDS and Silo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with LLOYDS and Silo Pharma

The main advantage of trading using opposite LLOYDS and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LLOYDS position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.
The idea behind LLOYDS BKG GROUP and Silo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Directory
Find actively traded commodities issued by global exchanges